Cigna Corporation's Income Statement Analysis: Revenue to Profit Breakdown
Cigna Corporation's Income Statement Analysis: Revenue to Profit Breakdown
|
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$174.07 B | $180.52 B | $195.27 B | $247.12 B | $274.95 B | $277.94 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$151.12 B | $157.02 B | $170.09 B | $221.16 B | $248.97 B | $252.09 B |
Gross Profit Revenue minus cost of revenue. |
|
$22.95 B | $23.50 B | $25.18 B | $25.96 B | $25.99 B | $25.85 B |
|
Operating Expense
Costs to run business. |
|
$15.01 B | $15.05 B | $16.64 B | $16.55 B | $16.86 B | $16.33 B |
Research and Development Investment in innovation. |
|
- | - | - | - | - | - |
|
Sales, General and Administrative
Selling and admin costs. |
|
$12.79 B | $13.05 B | $14.32 B | $14.57 B | $14.00 B | $13.92 B |
General and Administrative Corporate overhead costs. |
|
- | - | - | - | - | $3.72 B |
Sales and Marketing Customer acquisition costs. |
|
- | - | - | - | - | - |
Other Expenses Other operating costs. |
|
$2.22 B | $2.01 B | $2.32 B | $1.98 B | $2.86 B | $2.41 B |
Operating Income Profit from operations. |
|
$7.94 B | $8.45 B | $8.54 B | $9.42 B | $9.13 B | $9.52 B |
|
Net Interest Income
Interest income minus expense. |
|
-$1.21 B | -$1.23 B | -$1.45 B | -$1.44 B | -$1.38 B | -$1.38 B |
Interest Income Income from investments. |
|
- | - | - | - | - | - |
Interest Expense Cost of borrowing. |
|
$1.21 B | $1.23 B | $1.45 B | $1.44 B | $1.38 B | $1.38 B |
Non-Operating Income (ex-Int) Income outside core operations. |
|
-$221.00 M | -$129.00 M | -$498.00 M | -$275.00 M | -$404.00 M | $194.00 M |
Total Other Income (Net) Net non-operating items. |
|
-$1.15 B | -$53.00 M | -$3.02 B | -$4.15 B | -$1.54 B | -$1.30 B |
Income Before Tax Profit before taxes. |
|
$6.79 B | $8.40 B | $5.51 B | $5.27 B | $7.59 B | $8.22 B |
Income Tax Expense Taxes on income. |
|
$1.37 B | $1.62 B | $141.00 M | $1.49 B | $1.35 B | $1.52 B |
|
Net Income
Final profit. |
|
$5.37 B | $6.70 B | $5.16 B | $3.43 B | $5.96 B | $6.29 B |
Net Income From Continuing Operations Profit from core business. |
|
$5.42 B | $6.78 B | $5.37 B | $3.78 B | $6.25 B | $6.70 B |
Net Income From Discontinued Operations Profit/loss from sold units. |
|
- | - | - | - | - | - |
Other Adjustments to Net Income Additional accounting adjustments. |
|
- | - | - | - | - | - |
Net Income Deductions Reductions from net income. |
|
- | - | - | - | - | - |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$15.89 | $21.66 | $17.57 | $12.25 | $22.30 | $23.72 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$15.75 | $21.41 | $17.39 | $12.12 | $22.17 | $23.58 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
337.96 M | 313.07 M | 296.88 M | 280.29 M | 265.95 M | 262.54 M |
Diluted Average Shares Outst. Shares including dilution. |
|
340.97 M | 313.07 M | 296.88 M | 283.22 M | 265.95 M | 264.22 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$8.16 B | $8.58 B | $9.03 B | $9.69 B | $9.53 B | $9.32 B |
EBITDA Earnings before interest, tax, D&A. |
|
$9.96 B | $10.44 B | $10.85 B | $11.45 B | $12.17 B | $11.93 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$1.80 B | $1.86 B | $1.81 B | $1.75 B | $2.63 B | $2.61 B |
| Company Report |
Cigna Corporation's Assets vs Liabilities & Equity
| Loading balance sheet when needed... |
| Loading cash flow statement when needed... |
| Loading profitability metrics when needed... |





